EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Pregnancy outcomes after first‐trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions

Mikako Goto iD, Tatsuhiko Anzai iD, Ritsuko Yamane, Naho Yakuwa iD, Kunihiko Takahashi iD, Atsuko Murashima

Congenital Anomalies · 2024

DOI: 10.1111/cga.12577 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Congenital Anomalies, 2024. Verfasst von Mikako Goto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pregnancy and Drug Information Center, The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Ja…. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Anti-Bacterial Agents, Fluoroquinolones, Pregnancy Outcome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the paucity of safety data on fluoroquinolone antibiotics in pregnancy, a prospective observational cohort study was conducted in pregnant women who sought help and advice on drug use at two teratology information institutes in Japan. The primary endpoint of the study was the incidence of major congenital anomalies. The study population included pregnant women exposed to (i) fluoroquinolones (fluoroquinolone group), (ii) β‐lactams (infectious control group), or (iii) other agents considered to be nonteratogenic in humans (nonteratogenic control group) during the first trimester. The frequency of major congenital anomalies was compared across groups using a logistic regression model that adjusted for maternal age, smoking status, drinking status, facility consulted, and time of consultation. The fluoroquinolone group consisted of 411 women who had 383 children born alive. The infectious control and nonteratogenic control groups consisted of 1416 and 1482 women who had 1322 and 1401 children born alive, respectively. The incidence of major congenital anomalies was 1.5%, 2.0%, and 1.6% in the fluoroquinolone group, infectious control, and nonteratogenic control groups, respectively. Logistic regression showed that fluoroquinolone exposure is not a significant risk factor for major congenital anomalies. In conclusion, first‐trimester exposure to fluoroquinolone antibiotics was not associated with increased maternal or fetal risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abnormalities, Drug-InducedAnti-Bacterial AgentsFluoroquinolonesPregnancy OutcomePregnancy Trimester, FirstAdultFemaleHumansPregnancyDatabases, FactualIncidenceJapanMaternal ExposureProspective StudiesRisk Factors

Stichwörter der Autor:innen

congenital anomalygarenoxacinlevofloxacinpregnancytosufloxacin

Substanzen

Anti-Bacterial AgentsFluoroquinolones

Autor:innen und Institutionen

  • Pregnancy and Drug Information Center, The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Pharmacy, Toranomon Hospital, Minato-ku, Japan.

ORCID-Profile: Mikako Goto, Tatsuhiko Anzai, Naho Yakuwa, Kunihiko Takahashi

Zitieren

APA

Goto, M., Anzai, T., Yamane, R., Yakuwa, N., Takahashi, K., & Murashima, A. (2024). Pregnancy outcomes after first‐trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions. Congenital Anomalies. https://doi.org/10.1111/cga.12577

Vancouver

Goto M, Anzai T, Yamane R, Yakuwa N, Takahashi K, Murashima A. Pregnancy outcomes after first‐trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions. Congenital Anomalies. 2024. doi:10.1111/cga.12577

BibTeX
@article{Goto2024,
  author = {Goto, Mikako and Anzai, Tatsuhiko and Yamane, Ritsuko and Yakuwa, Naho and Takahashi, Kunihiko and Murashima, Atsuko},
  title = {Pregnancy outcomes after first‐trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions},
  journal = {Congenital Anomalies},
  year = {2024},
  doi = {10.1111/cga.12577}
}
Kostenlos starten →